Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Catalent Inc (CTLT)

Catalent Inc (CTLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,709,208
  • Shares Outstanding, K 181,512
  • Annual Sales, $ 4,381 M
  • Annual Income, $ -1,043 M
  • EBIT $ -92 M
  • EBITDA $ 411 M
  • 60-Month Beta 1.16
  • Price/Sales 2.44
  • Price/Cash Flow 22.44
  • Price/Book 3.02

Options Overview Details

View History
  • Implied Volatility 21.53% ( -10.05%)
  • Historical Volatility 10.21%
  • IV Percentile 46%
  • IV Rank 27.35%
  • IV High 67.32% on 02/02/24
  • IV Low 4.30% on 08/29/24
  • Put/Call Vol Ratio 4.50
  • Today's Volume 44
  • Volume Avg (30-Day) 526
  • Put/Call OI Ratio 3.08
  • Today's Open Interest 46,804
  • Open Int (30-Day) 43,135

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.02
  • Number of Estimates 3
  • High Estimate 0.15
  • Low Estimate -0.05
  • Prior Year -0.33
  • Growth Rate Est. (year over year) +106.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.29 +2.37%
on 11/05/24
60.32 -1.07%
on 10/22/24
-0.51 (-0.84%)
since 10/21/24
3-Month
58.29 +2.37%
on 11/05/24
61.20 -2.49%
on 08/30/24
+0.26 (+0.45%)
since 08/21/24
52-Week
36.74 +62.43%
on 12/12/23
61.20 -2.49%
on 08/30/24
+19.83 (+49.79%)
since 11/21/23

Most Recent Stories

More News
Catalent Stock: Analyst Estimates & Ratings

Despite Catalent’s outperformance relative to the broader market over the past year, Wall Street analysts remain cautious about the stock’s prospects.

XLV : 144.09 (+0.85%)
CTLT : 59.67 (+1.14%)
$SPX : 5,953.99 (+0.62%)
Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up

Catalent, Inc. CTLT reported first-quarter fiscal 2025 adjusted loss per share of 13 cents, flat year over year. The figure was wider than the Zacks Consensus Estimate of a loss of 11 cents per share....

DGX : 164.08 (+1.71%)
BSX : 91.61 (+1.60%)
CTLT : 59.67 (+1.14%)
RMD : 243.55 (+0.83%)
Catalent: Fiscal Q1 Earnings Snapshot

Catalent: Fiscal Q1 Earnings Snapshot

CTLT : 59.67 (+1.14%)
What to Expect From Catalent's Next Quarterly Earnings Report

Catalent is expected to release its first-quarter earnings next month, and analysts expect a triple-digit profit surge.

XLV : 144.09 (+0.85%)
CTLT : 59.67 (+1.14%)
$SPX : 5,953.99 (+0.62%)
CTLT Stock Falls as Potential Hindrance to NVO Buyout Deal Increases

Shares of Catalent CTLT lost 0.9% on Oct. 23 with the rise in uncertainty related to its acquisition by Novo Holding following a report from Reuters on opposition from several large pharma companies as...

NVO : 102.74 (-2.40%)
CTLT : 59.67 (+1.14%)
LLY : 749.33 (-0.54%)
RHHBY : 35.3550 (+0.64%)
Catalent Stock Flat Following the Sell Agreement With Ardena

Catalent CTLT recently announced that it has entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in Somerset, NJ, to Ardena. Ardena is a Contract...

BSX : 91.61 (+1.60%)
CTLT : 59.67 (+1.14%)
BAX : 33.02 (+1.20%)
DVA : 164.62 (+2.00%)
The Zacks Analyst Blog Highlights AppLovin, Duolingo, Paramount, Twilio and Catalent

For Immediate ReleaseChicago, IL – October 4, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

APP : 318.33 (-2.12%)
TWLO : 102.29 (+3.91%)
CTLT : 59.67 (+1.14%)
PARAA : 23.38 (+5.98%)
DUOL : 342.20 (+3.34%)
More Interest Rate Cuts Ahead: 5 Growth Stocks to Benefit

Wall Street is currently riding on high expectations that the Fed will implement further cuts in the benchmark lending rate this year. In its September FOMC meeting, the central bank aggressively cut the...

APP : 318.33 (-2.12%)
TWLO : 102.29 (+3.91%)
CTLT : 59.67 (+1.14%)
PARAA : 23.38 (+5.98%)
DUOL : 342.20 (+3.34%)
Catalent Stock: Is CTLT Outperforming the Healthcare Sector?

Despite Catalent’s outperformance relative to the broader sector, Wall Street analysts remain cautious about the stock’s prospects.

XLV : 144.09 (+0.85%)
CTLT : 59.67 (+1.14%)
AMGN : 289.91 (+0.71%)
Do Options Traders Know Something About Catalent (CTLT) Stock We Don't?

Investors in Catalent, Inc. CTLT need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 18, 2024 $20 Put had some of the highest implied volatility...

CTLT : 59.67 (+1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Catalent, Inc. is a renowned global provider of advanced delivery technologies as well as development and manufacturing solutions for drugs (protein, cell, and gene therapy biologics) and consumer health products.

See More

Key Turning Points

3rd Resistance Point 59.51
2nd Resistance Point 59.28
1st Resistance Point 59.14
Last Price 59.67
1st Support Level 58.77
2nd Support Level 58.54
3rd Support Level 58.40

See More

52-Week High 61.20
Last Price 59.67
Fibonacci 61.8% 51.86
Fibonacci 50% 48.97
Fibonacci 38.2% 46.08
52-Week Low 36.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar